#Project/ä¼ªéŸ³
## Target
èƒ½å‘å‡ºæ­£å¸¸æ¸…æ™°æ˜Žäº®çš„å¥³å£°

## Resources
[è“è‰²å°ä¹¦(å£°ä¹)](x-devonthink-item://CFD97273-DD7C-45E9-8B20-3138A7E7A719)
[å£°éŸ³çš„è§£å‰–(å–‰å’™è§£å‰–)](x-devonthink-item://2DE113C1-D2A6-40FA-88A9-CF4489C5D322)

[å­—æ¯è¡¨](http://xh.5156edu.com/pinyi.html)

[voice feminization](https://www.youtube.com/watch?v=BfCS01MkbIY&list=PLYJkVI7LLpknvBww07jnsxbz-_Lkynsry)

![](https://picture-bed-1301848969.cos.ap-shanghai.myqcloud.com/20220527153004.png)


[patreon](https://www.patreon.com/m/2213555/posts)

[å­¦ä¹ èµ„æº](https://docs.google.com/spreadsheets/d/1F0zsAOoyfBXu63_U2zy0et0Ku1OxZ0DCDKUsEI5Ebjs/edit#gid=1676784532)

å­¦å¥½å£°éŸµè¾¨å››å£°ï¼Œé˜´é˜³ä¸ŠåŽ»è¦åˆ†æ˜Žã€‚  
éƒ¨ä½æ–¹æ³•éœ€æ‰¾å‡†ï¼Œå¼€é½å’Œæ’®å±žå£å½¢ã€‚  
èˆŒæ ¹é«˜ç‹—å·¥è€•æ•…ï¼ŒèˆŒé¢æœºç»“æ•™å°–ç²¾ã€‚  
ç¿˜èˆŒä¸»äº‰çœŸå¿—ç…§ï¼Œå¹³èˆŒèµ„è´£æ—©åœ¨å¢žã€‚  
æ“¦éŸ³å‘ç¿»é£žåˆ†å‰¯ï¼Œé€æ°”èŒ¶æŸ´äº§å½»ç§°ã€‚  
åˆå£å‘¼å±‹æž¯æ¹–å¤ï¼Œå¼€å£æ²³å¡æ­Œå®‰äº‰ã€‚  
å˜´æ’®è™šå­¦å¯»å¾å‰§ï¼Œé½é½¿è¡£ä¼˜æ‘‡å¤œè‹±ã€‚  
å‰é¼»æ©å› çƒŸå¼¯ç¨³ï¼ŒåŽé¼»æ˜‚è¿Žä¸­æ‹¥ç”Ÿã€‚  
å’¬ç´§å­—å¤´å½’å­—å°¾ï¼Œé˜´é˜³ä¸ŠåŽ»è®°å˜å£°ã€‚  
å¾ªåºæ¸è¿›åšæŒç»ƒï¼Œä¸éš¾è¾¾åˆ°çº¯å’Œæ¸…ã€‚

[å››å­—æ­Œ](https://www.bilibili.com/video/BV19J411a7uB)


[ç»ƒä¹ å£°éŸ³å¥³æ€§åŒ–çš„äº”ä¸ªåŽŸåˆ™](https://www.patreon.com/posts/5-key-basics-for-34795850)

[å˜ç»†ç»ƒä¹ ](https://docs.google.com/document/d/16Yv30tSd7qRvhULK-mdmw8jVWiiiVISGn0vPcmEgHtU/edit)


[å‘å£°åŽŸç†](https://newt.phys.unsw.edu.au/jw/voice.html)

## Progress
#todo è®°ç¬”è®°-å£°éŸ³çš„è§£å‰– è‚Œè‚‰ç›¸å…³çš„çŸ¥è¯†

### [[2022-04-20 ðŸ“…]]
çˆ¬éŸ³èŠ‚
å£°å¸¦é—­åˆ

çˆ¬éŸ³ åº”è¯¥ä¸ç”¨åŠ›

å£°å¸¦æŽ§åˆ¶åŠ›åº”å½“åŠ å¼º

è¾¹ç¼˜æŒ¯åŠ¨

### [[2022-05-08 ðŸ“…]]
heéŸ³, èˆŒå¤´ç¿˜èµ·æ¥é¡¶ä½ä¸Šé¢šæˆ–è®¸ä¼šæ¯”è¾ƒå¥½
æ ‡å‡†:
![[0508S.mp3]]
æˆ‘çš„:
![[0508Z.mp3]]


### [[2022-05-31 ðŸ“…]]
![](https://picture-bed-1301848969.cos.ap-shanghai.myqcloud.com/20220531225758.png)
ç”·æ€§å’Œå¥³æ€§éšç€å¹´é¾„å¢žé•¿åŸºéŸ³éƒ½ä¼šä¸‹é™

åœ¨ Fundamental voice frequence during normal and abnormal growth, and after androgen treatment. ä¸­, ä»–ä»¬åœ¨10å²å‰(é’æ˜¥æœŸå‰)çš„å­©å­èº«ä¸Šä¹Ÿå‘çŽ°äº†å£°éŸ³çš„æ€§åˆ«å·®å¼‚, ç”·å­©çš„SFFå’ŒLFéƒ½ä¼šæ›´ä½Ž. (ä½œè€…çŒœæµ‹å¯¼è‡´è¿™æ ·çš„åŽŸå› æœ‰: æµ‹é‡æ–¹æ³•çš„é—®é¢˜, è¯­è¨€å­¦æˆ–æ–‡åŒ–ä¸Šçš„åŽŸå› )


Quantifying the impact of androgen therapy on the female larynx
é›„æ€§æ¿€ç´ å¯¹å–‰å’™çš„å½±å“
>Androgen exposure in female patients, such as is seen in congenital adrenal hyperplasia or from treatment with exogenous testosterone results in androglottia (masculine voice characteristics with typical male prominentia larynges) [3]. Histologically, testosterone administration produces thyroarytenoid muscle fiber hypertrophy and hyperplasia, epithelial parakeratosis and squamous metaplasia, and hyperplasia of seromucinous glands after 4 weeks and which is permanent after 8 weeks [4]. Perceptually, females undergoing gender reassignment have noted voice changes from anywhere from a few weeks to more than a year after starting testosterone therapy as well as decreased pitch range and singing ability, although these changes are not well quantified

Voice in female-to-male transsexual persons after long-term androgen therapy: Voice in Female-to-Male Transsexuals ä¸­æåˆ°ç»è¿‡æ¿€ç´ æ²»ç–—çš„FTMçš„å£°éŸ³ä¹Ÿä¸éƒ½æ˜¯æ²¡æœ‰é—®é¢˜çš„
>Although FMT after long-term androgen therapy as a group display an acceptable male voice, individual results confirm the previous finding that voice change in FMT is not always totally unproblematic.

**é—®é¢˜:** ä»€ä¹ˆæ˜¯CAG repeat?